Last reviewed · How we verify
NCT06986564
Evaluation of Decision Compatibility Between a Multidisciplinary Cancer Board and ChatGPT-4O
trial in Cancer in 100 participants. Completed in 1 May 2025.
30 January 2025
Quick facts
| Lead sponsor | Sebahattin Celik MD |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 November 2024 |
| Primary completion | 30 January 2025 |
| Estimated completion | 1 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Cancer — all drugs for Cancer →
- Artificial Intelligence — all drugs for Artificial Intelligence →
Sponsor
Sebahattin Celik MD
Who can join
18 and older, any sex, with Cancer or Artificial Intelligence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to compare the decisions of a multidisciplinary cancer board at Van research and educational Hospital with those generated by ChatGPT-4O. Patient data, including age, gender, comorbidities, clinical findings, laboratory results, radiology, and pathology reports, will be collected and recorded in patient files. These records will then be converted into a textual format appropriate for input into the ChatGPT-4O model. Statistical analyses will be conducted to assess the level of agreement between the board's decisions and those of ChatGPT-4O, providing insights into their compatibility and potential utility in clinical practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06986564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Sebahattin Celik MD trials
Trials by the same sponsor.
- NCT07492329 — Antibiotics vs Surgery in Acute Appendicitis · NA · active not recruiting
- NCT05872932 — Outcome of Combined Botulinum Toxin A Injection and Gastric Balloon Implantation in Obesity Treatment · Phase 2, PHASE3 · completed
- NCT05648084 — Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06986564 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sebahattin Celik MD
- Last refreshed: 23 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06986564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing